These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Caruso R; Warner N; Inohara N; Núñez G Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305 [TBL] [Abstract][Full Text] [Related]
28. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Abais JM; Xia M; Zhang Y; Boini KM; Li PL Antioxid Redox Signal; 2015 May; 22(13):1111-29. PubMed ID: 25330206 [TBL] [Abstract][Full Text] [Related]
29. A long-awaited merger of the pathways mediating host defence and programmed cell death. Blander JM Nat Rev Immunol; 2014 Sep; 14(9):601-18. PubMed ID: 25145756 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of NLRP3 inflammasome activation. Sutterwala FS; Haasken S; Cassel SL Ann N Y Acad Sci; 2014 Jun; 1319(1):82-95. PubMed ID: 24840700 [TBL] [Abstract][Full Text] [Related]
31. IAPs, regulators of innate immunity and inflammation. Estornes Y; Bertrand MJ Semin Cell Dev Biol; 2015 Mar; 39():106-14. PubMed ID: 24718315 [TBL] [Abstract][Full Text] [Related]
32. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway. Jakopin Ž J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857 [TBL] [Abstract][Full Text] [Related]
33. Newly described pattern recognition receptors team up against intracellular pathogens. Broz P; Monack DM Nat Rev Immunol; 2013 Aug; 13(8):551-65. PubMed ID: 23846113 [TBL] [Abstract][Full Text] [Related]
34. Activation and regulation of the inflammasomes. Latz E; Xiao TS; Stutz A Nat Rev Immunol; 2013 Jun; 13(6):397-411. PubMed ID: 23702978 [TBL] [Abstract][Full Text] [Related]
35. Recognition of bacteria by inflammasomes. von Moltke J; Ayres JS; Kofoed EM; Chavarría-Smith J; Vance RE Annu Rev Immunol; 2013; 31():73-106. PubMed ID: 23215645 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological insights and role of bufalin (bufadienolides) in inflammation modulation: a narrative review. Kaur G; Devi S; Sharma A; Sood P Inflammopharmacology; 2024 Oct; 32(5):3057-3077. PubMed ID: 39012431 [TBL] [Abstract][Full Text] [Related]
37. IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease. Seidelin JB; Jensen S; Hansen M; de Carvalho Bronze MR; Cuchet-Lourenҫo D; Nejentsev S; LaCasse EC; Nielsen OH Clin Exp Immunol; 2024 Feb; 215(3):291-301. PubMed ID: 37583360 [TBL] [Abstract][Full Text] [Related]
38. XIAP promotes the expansion and limits the contraction of CD8 T cell response through cell extrinsic and intrinsic mechanisms respectively. Thakker P; Ariana A; Hajjar S; Cai D; Rijal D; Sad S PLoS Pathog; 2023 Jun; 19(6):e1011455. PubMed ID: 37347786 [TBL] [Abstract][Full Text] [Related]
39. The Deubiquitinase OTUB1 Is a Key Regulator of Energy Metabolism. Ruiz-Serrano A; Boyle CN; Monné Rodríguez JM; Günter J; Jucht AE; Pfundstein S; Bapst AM; Lutz TA; Wenger RH; Scholz CC Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163456 [TBL] [Abstract][Full Text] [Related]